back to top
الجمعة, نوفمبر 20, 2026
الرئيسية Company News Nahdi Delivers 9.4% Revenue Growth & 6.5% Net Profit Growth in Q3...

Nahdi Delivers 9.4% Revenue Growth & 6.5% Net Profit Growth in Q3 2026

Nahdi Medical Company reports revenue and profit growth in Q3 2026

Nahdi Medical Company (“Nahdi” or “the Company”), Saudi Arabia’s leading purpose-driven healthcare and wellbeing company, today reported its financial results for the third quarter of 2026 (“Q3 2026”) and for the nine months of 2026 (“9M 2026”).

Financial Performance

Nahdi delivered robust top-line and bottom-line growth during the third quarter of 2026, with revenue increasing by 9.4% year-on-year to SAR 2,692.0 million and net profit rising by 6.5% to SAR 171.8 million. The Company continued its strategic investment agenda across Healthcare, regional expansion, digital transformation, and AI-enabled capabilities. These results reflect Nahdi’s continued focus on deepening guest engagement by delivering exceptional experiences, expanding accessibility, and offering tailored healthcare and well-being solutions that address evolving needs and preferences.

For the nine months ended 30 September 2026, Nahdi’s revenue increased by 7.0% year-on-year to SAR 8,160.7 million, driven by continued momentum in the Retail business and strong growth across Healthcare and regional expansion businesses. Gross profit increased by 3.6% to SAR 2,952.3 million, supported by revenue growth across key business segments. The Company reported net profit of SAR 622.7 million, compared with SAR 654.8 million in the same period last year, a decline of 4.9%. Excluding the non-recurring release of SAR 17.8 million in zakat provisions recognized in the same period last year, net profit declined by 2.3%, reflecting higher logistics costs and accelerated investments in future strategic initiatives. EBITDA remained flat, reflecting the Company’s ability to sustain operating profit while continuing to invest for future Growth. These results reflect the strength of Nahdi’s business model and disciplined execution of its guest-centric strategy, supported by a deep understanding of evolving Guest needs and shopping behaviors. Through continued investments in innovation, own brands, Healthcare services, and omnichannel capabilities, Nahdi is enhancing the Guest experience, strengthening loyalty, and building differentiated growth platforms that drive sustainable long-term growth, profitability, and shareholder value. This commitment is further reflected in Nahdi’s brand equity score reaching an all-time high of 7.5, reinforcing its market leadership and the enduring trust of its Guests.

The Retail business remained the primary growth driver, with total Retail revenue increasing by 5.7%, supported by solid performance in both Pharma and Front Shop segments, which achieved a market share gain of more than 100bps despite challenging market dynamics. The Company continued to expand its Retail footprint, reaching 1,219 stores, supporting its strategy of being within a five-minute drive of 95% of the population. Nahdi also continued investing in its differentiated omnichannel model, with online sales contributing 30.6% of Retail revenue, compared with 25.7% in the same period last year. This momentum was supported by NAHDI NOW 30-minute delivery service and AI tools that enable more personalized guest experiences. This performance reflects the continued progress in the Company’s digital transformation, underpinned by investments in advanced digital and AI-enabled capabilities.

Private label products maintained strong momentum, with revenue increasing by 15.6% and their contribution to Retail revenue reaching 19.1%, compared with 17.5% in the same period last year. This performance reflects growing guest trust in Nahdi’s own and differentiated offerings and the continued expansion of locally manufactured and Saudi-born brands. Notably, “Babywell” the Saudi made home grown brand entered into the 100 million revenue club, reinforcing the guest trust in Nahdi’s own brands. The increasing contribution of private label products reinforces the Company’s value-focused strategy, strengthens guest loyalty, and supports long-term profitability while enabling continued investment in future growth initiatives.

The Healthcare business maintained its growth trajectory, with revenue increasing by 32.1% year-on-year, supported by its expanding physical network and integrated digital healthcare ecosystem. Nahdi expanded its reach to the Eastern Region by opening another new polyclinic in Dammam, thus, reaching total of 15 polyclinics operating across 10 cities of the Kingdome. Nahdicare continued to offer differentiated, personalised, and accessible services. Healthcare remains a key strategic growth pillar for the Company, supporting revenue growth and enhancing profitability over the medium term.

Nahdi delivered a solid performance during the first nine months of 2026, demonstrating the strength of its business fundamentals and continued execution of its strategic priorities. The Company advanced across Retail, Healthcare, digital and AI-enabled capabilities, reinforcing its competitive position in a dynamic market. Central to this performance was Nahdi’s focus on delivering more personalised, accessible, and seamless health and well-being experiences for guests. Looking ahead, Nahdi remains committed to disciplined investment in innovation, digital transformation, and healthcare infrastructure to support long-term value creation for guests, shareholders, and the broader community.